| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| IL138930A0 (en) | 1998-05-15 | 2001-11-25 | Genentech Inc | Il-17 homologies polypeptides and therapeutic uses thereof |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| US6929938B2 (en) | 2001-08-15 | 2005-08-16 | Millennium Pharmaceuticals, Inc. | 25501, a human transferase family member and uses therefor |
| US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
| EP1163252A4 (en)* | 1999-02-25 | 2004-04-07 | Univ Jefferson | COMPOSITIONS, KITS AND METHODS RELATING TO THE HUMAN FEZ1 GENE, A NEW TUMOR SUPPRESSOR |
| WO2000050458A1 (en)* | 1999-02-26 | 2000-08-31 | Smithkline Beecham Corporation | Cloning of a p2y-like 7tm receptor (axor17) |
| JP2004506402A (en)* | 1999-03-23 | 2004-03-04 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 48 human secretory proteins |
| AU3330700A (en) | 1999-03-29 | 2000-10-16 | Tasuku Honjo | Novel cytidine deaminase |
| CA2380550C (en) | 1999-08-12 | 2011-02-01 | Urogenesys, Inc. | C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| EP1892249A1 (en)* | 1999-09-01 | 2008-02-27 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7083944B1 (en)* | 1999-10-27 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
| US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
| US7005499B1 (en)* | 1999-11-18 | 2006-02-28 | Genentech, Inc. | Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| EP1878796A3 (en)* | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1669371A3 (en)* | 1999-12-01 | 2006-06-21 | Genentech, Inc. | Composition and methods for the diagnosis of tumours |
| CN1300781A (en)* | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| IL150873A0 (en) | 2000-01-26 | 2003-02-12 | Agensys Inc | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| US6953682B2 (en) | 2000-02-10 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor |
| US7078205B2 (en) | 2000-02-17 | 2006-07-18 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor |
| US20020082212A1 (en)* | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
| US20020090705A1 (en)* | 2000-07-14 | 2002-07-11 | Rachel Meyers | 62088, a novel human nucleoside phosphatase family member and uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| JP2003527860A (en)* | 2000-03-23 | 2003-09-24 | イミューソル インコーポレイテッド | BRCA-1 regulatory factors and methods of use |
| WO2001073050A2 (en) | 2000-03-24 | 2001-10-04 | Millennium Pharmaceuticals, Inc. | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| US20030198953A1 (en)* | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
| US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
| AU5719501A (en) | 2000-04-25 | 2001-11-07 | Lexicon Genetics Inc | Novel human kinase proteins and polynucleotides encoding the same |
| WO2001081586A2 (en)* | 2000-04-26 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | 21657, a human short-chain dehydrogenase and uses thereof |
| US6808876B1 (en)* | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
| US20030096313A1 (en)* | 2000-05-12 | 2003-05-22 | Burkhard Scharm | Novel serine-threonine kinase-4 |
| EP1158001B1 (en)* | 2000-05-26 | 2007-11-14 | F. Hoffmann-La Roche Ag | A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis |
| EP1307545A2 (en)* | 2000-05-26 | 2003-05-07 | Bayer Aktiengesellschaft | REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| DE10027170A1 (en)* | 2000-05-31 | 2001-12-13 | Schering Ag | Human PEM as a target for fertility control |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001093805A2 (en)* | 2000-06-02 | 2001-12-13 | The Brigham & Women's Hospital, Inc. | FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| AU6531101A (en)* | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU6604901A (en)* | 2000-06-05 | 2001-12-17 | Bayer Aktiengesellschaft | Regulation of human hm74-like g protein coupled receptor |
| EP1287029A2 (en)* | 2000-06-09 | 2003-03-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| AU2001268435A1 (en)* | 2000-06-15 | 2001-12-24 | Millennium Pharmaceuticals, Inc. | 23680, a novel human aminotransferase and uses therefor |
| WO2001096546A2 (en)* | 2000-06-16 | 2001-12-20 | Incyte Genomics, Inc. | Protein phosphatases |
| CA2709771A1 (en)* | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| EP1325114A2 (en)* | 2000-06-26 | 2003-07-09 | Millennium Pharmaceuticals, Inc. | A human beta-ketoacyl synthase (46619) and uses thereof |
| EP1309684A2 (en)* | 2000-06-27 | 2003-05-14 | Curagen Corporation | Polynucleotides and polypeptides encoded thereby |
| US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
| US6774223B2 (en) | 2000-06-28 | 2004-08-10 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| WO2002002761A2 (en)* | 2000-06-30 | 2002-01-10 | Millennium Pharmaceuticals, Inc. | 57658, a human uridine kinase and uses thereof |
| AU2001273239A1 (en)* | 2000-07-07 | 2002-01-21 | Incyte Genomics, Inc. | Transporters and ion channels |
| AU2001271843A1 (en)* | 2000-07-07 | 2002-01-21 | Incyte Genomics, Inc. | Gtp-binding proteins |
| US6740751B2 (en) | 2000-07-18 | 2004-05-25 | Board Of Regents, The University Of Texas System | Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| US20030171324A1 (en)* | 2000-07-18 | 2003-09-11 | Shyam Ramakrishnan | Regulation of human desc1-like serine protease |
| JP2004514420A (en)* | 2000-07-20 | 2004-05-20 | ジェネンテック・インコーポレーテッド | Secreted and transmembrane polypeptides and nucleic acids encoding them |
| AU2001287629B2 (en)* | 2000-07-25 | 2006-08-17 | Merck Patent Gmbh | Novel protein containing ring finger domaine R1P4 |
| AU2001277202A1 (en)* | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-ras/rerg protein and related reagents and methods of use thereof |
| WO2002008281A2 (en)* | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-cad protein and related reagents and methods of use thereof |
| US7335732B2 (en) | 2000-08-01 | 2008-02-26 | Genentech, Inc. | PRO9799 polypeptides |
| EP1657254A3 (en)* | 2000-08-01 | 2006-06-07 | Genentech, Inc. | Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| EP1315431A1 (en)* | 2000-08-02 | 2003-06-04 | Millennium Pharmaceuticals, Inc. | A human gtp-releasing factor family member (15368) and uses therefor |
| JP2004527210A (en) | 2000-08-02 | 2004-09-09 | ザ ジョンズ ホプキンス ユニバーシティー | Evaluation method of endothelial cell expression pattern |
| US6924364B2 (en) | 2000-08-04 | 2005-08-02 | Zymogenetics, Inc. | Human secreted protein, Zzp1 |
| WO2002012285A2 (en) | 2000-08-10 | 2002-02-14 | Board Of Regents, The University Of Texas System | The tumor suppressor car-1 |
| EP1307566A2 (en)* | 2000-08-11 | 2003-05-07 | MERCK PATENT GmbH | Mitogen activated kinase |
| EP1326985A1 (en)* | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identification of a human n-terminal acetyltransferase gene |
| WO2002016586A2 (en) | 2000-08-21 | 2002-02-28 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
| WO2002016587A2 (en)* | 2000-08-21 | 2002-02-28 | Incyte Genomics, Inc. | Microtubule-associated proteins and tubulins |
| WO2002016579A2 (en)* | 2000-08-24 | 2002-02-28 | Eli Lilly And Company | Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| AU2001284176A1 (en)* | 2000-08-28 | 2002-03-13 | Astrazeneca Ab | Molecules involved in the regulation of insulin in resistance syndrome (irs) |
| PT1313850E (en) | 2000-08-28 | 2008-11-18 | Agensys Inc | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| CA2420902A1 (en)* | 2000-08-28 | 2002-03-07 | Craig A. Rosen | 18 human secreted proteins |
| WO2002018552A2 (en)* | 2000-08-30 | 2002-03-07 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| WO2002018577A2 (en)* | 2000-08-30 | 2002-03-07 | Millennium Pharmaceuticals, Inc. | 48921, a novel human gtp releasing factor and uses therefor |
| AU2002210464A1 (en)* | 2000-08-30 | 2002-03-13 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| US20020091238A1 (en)* | 2000-08-30 | 2002-07-11 | Curtis Rory A.J. | 54370, a novel human sulfate transporter and uses therefor |
| AU2001288600A1 (en)* | 2000-08-31 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 62112, a novel human dehydrogenase and uses thereof |
| CA2421265A1 (en)* | 2000-09-05 | 2002-03-14 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
| MXPA03001930A (en) | 2000-09-05 | 2003-06-19 | Amgen Inc | Tnf receptor-like molecules and uses thereof. |
| AU2001288999A1 (en)* | 2000-09-08 | 2002-03-22 | Millennium Pharmaceuticals, Inc. | 38646, a guanine nucleotide exchange factor and uses therefor |
| US6372468B1 (en) | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6391606B1 (en)* | 2000-09-14 | 2002-05-21 | Pe Corporation | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| US20040048245A1 (en)* | 2000-10-05 | 2004-03-11 | Shimkets Richard A. | Novel human proteins, polynucleotides encoding them and methods of using the same |
| AU2002220613A1 (en)* | 2000-10-11 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| AU2002211597A1 (en)* | 2000-10-11 | 2002-04-22 | Millennium Pharmaceuticals, Inc. | 8843, a human dual specificity phosphatase family member and uses therefor |
| AU2002211715A1 (en)* | 2000-10-12 | 2002-04-22 | The Texas A And M University System | Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| EP1474528A4 (en)* | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS |
| US6531297B2 (en)* | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| AU2002249787A1 (en) | 2000-10-25 | 2002-08-19 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| WO2002036781A2 (en)* | 2000-10-31 | 2002-05-10 | Bayer Aktiengesellschaft | Regulation of human glutathione-s-transferase |
| AU2002229011A1 (en)* | 2000-11-09 | 2002-05-21 | Glaxo Group Limited | Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| EP1349934A2 (en) | 2000-11-20 | 2003-10-08 | Diadexus, Inc. | Compositions and methods relating to breast specific genes and proteins |
| AU2001297765A1 (en)* | 2000-12-05 | 2002-10-21 | Incyte Genomics, Inc. | Ligases |
| JP2004524825A (en) | 2000-12-07 | 2004-08-19 | ザイモジェネティクス，インコーポレイティド | Adipocyte complement-related protein ZACRP3X2 |
| AU2002227365A1 (en) | 2000-12-07 | 2002-06-18 | Chiron Corporation | Endogenous retroviruses up-regulated in prostate cancer |
| CA2439800A1 (en)* | 2000-12-14 | 2002-06-20 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| US20020142376A1 (en)* | 2000-12-20 | 2002-10-03 | Gennady Merkulov | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| JP2004536566A (en) | 2000-12-22 | 2004-12-09 | ブリストル−マイヤーズ スクイブ カンパニー | Novel human leucine-rich repeat-containing protein HLRRSI1 preferentially expressed in the small intestine |
| US7892730B2 (en) | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| US6423521B1 (en)* | 2000-12-28 | 2002-07-23 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002053591A1 (en)* | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf12 and methods of use |
| WO2002053754A2 (en)* | 2001-01-08 | 2002-07-11 | Lexicon Genetics Incorporated | Human protease and polynucleotides encoding the same |
| JP2004524024A (en)* | 2001-01-30 | 2004-08-12 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Novel nucleic acid and polypeptide molecules |
| EP1409536A2 (en)* | 2001-02-12 | 2004-04-21 | Curagen Corporation | Human proteins and nucleic acids encoding same |
| EP1637601A3 (en)* | 2001-02-21 | 2006-03-29 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
| US7125703B2 (en) | 2001-03-13 | 2006-10-24 | Dendreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
| AU2002250143A1 (en)* | 2001-03-16 | 2002-10-03 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
| CA2441378A1 (en) | 2001-03-22 | 2002-10-03 | Dendreon San Diego Llc | Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| WO2002077267A2 (en) | 2001-03-27 | 2002-10-03 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| US6913904B2 (en)* | 2001-03-27 | 2005-07-05 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| ATE512216T1 (en) | 2001-04-10 | 2011-06-15 | Agensys Inc | NUCLEIC ACID AND THIS CORRESPONDING PROTEIN, CALLED 184P1E2, SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER |
| EP2280030A3 (en) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| IL158293A0 (en) | 2001-04-10 | 2004-05-12 | Agensys Inc | Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same |
| CA2483507A1 (en)* | 2001-04-24 | 2002-10-31 | Isis Innovation Limited | Enzyme and snp marker for disease |
| CA2445309A1 (en)* | 2001-04-24 | 2002-11-07 | Otsuka Pharmaceutical Co., Ltd. | Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| KR100781931B1 (en) | 2001-05-07 | 2007-12-04 | 시오노기세이야쿠가부시키가이샤 | Polypeptides Used as Angiogenic Markers and DNAs thereof |
| AU2002314048A1 (en)* | 2001-05-09 | 2002-11-18 | Bayer Aktiengesellschaft | Regulation of human phosphatidic acid phosphatase type 2c-like protein |
| WO2002092841A2 (en) | 2001-05-14 | 2002-11-21 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
| US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| AU2002311535A1 (en)* | 2001-06-26 | 2003-01-08 | Decode Genetics Ehf. | Nucleic acids encoding protein kinases |
| GB2399085A (en)* | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ12 |
| AU2002359242A1 (en)* | 2001-08-17 | 2003-04-22 | Incyte Genomics, Inc. | Intracellular signaling molecules |
| US7270960B2 (en)* | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| WO2003023063A1 (en)* | 2001-09-07 | 2003-03-20 | Sankyo Company, Limited | Method of judging onset risk of diabetes |
| WO2003040369A2 (en)* | 2001-09-17 | 2003-05-15 | Molecular Engines Laboratories | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| WO2003025175A2 (en)* | 2001-09-17 | 2003-03-27 | Molecular Engines Laboratories | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| JP2005534279A (en) | 2001-09-28 | 2005-11-17 | ブリガム ヤング ユニバーシティ | Novel cyclooxygenase variants and methods of use |
| EP1439225A4 (en) | 2001-10-04 | 2005-10-26 | Kansai Tech Licensing Org Co | Dr5 gene promoter and siah-1 gene promoter |
| US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| WO2003031607A1 (en)* | 2001-10-10 | 2003-04-17 | Bayer Healthcare Ag | Regulation of human short-chain dehydrogenase/reductase |
| ATE364690T1 (en) | 2001-11-09 | 2007-07-15 | Proteologics Inc | POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS |
| AU2002365162A1 (en) | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
| CA2468145A1 (en)* | 2001-11-21 | 2003-05-30 | Japan Science And Technology Agency | Transcriptional factors for the huntington's disease gene |
| US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
| AU2002339697A1 (en)* | 2001-12-19 | 2003-06-30 | Genset S.A. | Gmg-5 polynucleotides and polypeptides and uses thereof |
| JP2003245084A (en) | 2001-12-20 | 2003-09-02 | Morinaga Milk Ind Co Ltd | Novel gene useful for diagnosis and treatment of corpus callosum or sperm dysplasia, and use thereof |
| DE10163467A1 (en)* | 2001-12-21 | 2003-11-27 | Axaron Bioscience Ag | New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators |
| US6759222B2 (en) | 2002-01-02 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14815, a human kinase family member and uses therefor |
| WO2003057870A1 (en)* | 2002-01-07 | 2003-07-17 | Bayer Healthcare Ag | Human phosphatidic acid phosphatase type 2-like protein |
| WO2003060109A2 (en)* | 2002-01-15 | 2003-07-24 | Bayer Healthcare Ag | Human subtilisin/kexin-like convertase |
| AU2003205611A1 (en)* | 2002-01-15 | 2003-07-30 | Medigene Ag | Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| JPWO2003062429A1 (en)* | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | New serine protease |
| US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| EP1338609A1 (en)* | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | A further KDR receptor and the use thereof |
| CA2478271A1 (en)* | 2002-03-05 | 2003-09-18 | Applera Corporation | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| GB2388113A (en)* | 2002-03-06 | 2003-11-05 | Oxford Glycosciences | B-cell malignancy-associated protein |
| CA2992643C (en) | 2002-03-13 | 2019-06-18 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
| JP3949111B2 (en)* | 2002-03-19 | 2007-07-25 | 田辺製薬株式会社 | Novel G protein-coupled receptor and gene thereof |
| US7527935B2 (en) | 2002-03-19 | 2009-05-05 | Mitsubishi Tanabe Pharma Corporation | G-protein coupled receptor having eicosanoid as ligand and gene thereof |
| GB0206684D0 (en)* | 2002-03-21 | 2002-05-01 | Babraham Inst | Novel proteins |
| US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| US7329502B2 (en) | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
| JP2004041003A (en)* | 2002-05-17 | 2004-02-12 | Takeda Chem Ind Ltd | New protein, its dna and use thereof |
| EP1507553A2 (en) | 2002-05-29 | 2005-02-23 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Pancreas-specific proteins |
| US7198899B2 (en) | 2002-06-03 | 2007-04-03 | Chiron Corporation | Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers |
| PT1513934E (en) | 2002-06-06 | 2011-05-11 | Oncotherapy Science Inc | Genes and polypeptides relating to human colon cancers |
| AU2003276679A1 (en) | 2002-06-13 | 2003-12-31 | Chiron Corporation | Vectors for expression of hml-2 polypeptides |
| JPWO2004009626A1 (en)* | 2002-07-22 | 2005-11-17 | アステラス製薬株式会社 | Rheumatoid arthritis-related novel gene |
| AU2003256074B2 (en) | 2002-08-14 | 2011-02-03 | National Institute Of Advanced Industrial Science And Technology | Novel N-acetylgalactosamine transferases and nucleic acids encoding the same |
| AU2003243151A1 (en)* | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| WO2004018518A1 (en)* | 2002-08-23 | 2004-03-04 | Japan Science And Technology Agency | Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| AU2003250989A1 (en)* | 2002-08-27 | 2004-03-19 | Epigenomics Ag | Method and nucleic acids for the analysis of breast cell proliferative disorders |
| US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
| DE60325628D1 (en) | 2002-09-30 | 2009-02-12 | Oncotherapy Science Inc | GENES AND POLYPEPTIDES IN CONNECTION WITH HUMAN PANCREATIC CARCINOMAS |
| WO2004035823A2 (en)* | 2002-10-17 | 2004-04-29 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| AU2002952216A0 (en)* | 2002-10-23 | 2002-11-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
| US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| CA2506066A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| AU2003287764B2 (en)* | 2002-12-13 | 2010-01-21 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| AU2002953341A0 (en)* | 2002-12-13 | 2003-01-09 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| WO2004070025A2 (en)* | 2003-02-05 | 2004-08-19 | Juan Saus | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| EP1445614A1 (en)* | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| US7074891B2 (en)* | 2003-02-07 | 2006-07-11 | Posco | Leukocyte stimulating peptides |
| DK1597391T3 (en) | 2003-02-20 | 2009-01-12 | Genomic Health Inc | Use of intron RNA to measure gene expression |
| EP1600458A4 (en)* | 2003-03-04 | 2006-10-25 | Astellas Pharma Inc | Novel gene relating to fibrotic conditions |
| SI2248899T1 (en)* | 2003-03-19 | 2015-07-31 | Biogen Ma Inc. | NOGO receptor binding protein |
| ITRM20030149A1 (en) | 2003-04-02 | 2004-10-03 | Giuliani Spa | ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD |
| EP1641810B2 (en) | 2003-06-24 | 2017-04-19 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
| DK1644858T3 (en) | 2003-07-10 | 2018-01-22 | Genomic Health Inc | Functional clothing with at least one outer layer and inner membrane. |
| WO2005014818A1 (en) | 2003-08-08 | 2005-02-17 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| US20050136434A1 (en)* | 2003-08-12 | 2005-06-23 | Mai Xu | Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
| US20070178458A1 (en)* | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
| TW200517503A (en)* | 2003-09-10 | 2005-06-01 | Japan Science & Tech Agency | Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| CA2539715C (en)* | 2003-10-02 | 2015-02-24 | Glaxosmithkline Biologicals S.A. | Pertussis antigens and use thereof in vaccination |
| US8329660B2 (en) | 2003-10-03 | 2012-12-11 | The Brigham And Women's Hospital, Inc. | Tim-3 ligands and methods thereof |
| WO2005040791A2 (en)* | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) |
| US20050255560A1 (en)* | 2003-11-21 | 2005-11-17 | Zeren Gao | Ztnf11, a tumor necrosis factor |
| CA2549164A1 (en)* | 2003-12-05 | 2005-06-23 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| AU2004309396B2 (en) | 2003-12-23 | 2010-05-13 | Genomic Health, Inc. | Universal amplification of fragmented RNA |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| AU2005227148B2 (en)* | 2004-03-02 | 2010-11-11 | The Johns Hopkins University | Mutations of the PIK3CA gene in human cancers |
| TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| WO2005090569A1 (en)* | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
| US9845344B2 (en)* | 2004-03-30 | 2017-12-19 | Hoba Therapeutics Aps | Therapeutic use of a growth factor, NsG33 |
| EP2947160B1 (en) | 2004-04-09 | 2017-07-12 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| WO2005118832A2 (en)* | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
| JP4960865B2 (en) | 2004-06-24 | 2012-06-27 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Treatment of conditions related to demyelination |
| US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
| WO2006013661A1 (en)* | 2004-08-05 | 2006-02-09 | Toagosei Co., Ltd. | Crohn’s disease antibody epitope peptide and reagent for testing crohn’s disease |
| HUE051605T2 (en) | 2004-11-05 | 2021-03-01 | Nsabp Found Inc | Predicting response to chemotherapy using gene expression markers |
| EP1815014B1 (en) | 2004-11-05 | 2012-03-21 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| EP1817340B1 (en) | 2004-11-12 | 2012-05-16 | Xencor, Inc. | Fc variants with altered binding to fcrn |
| CA2598251A1 (en) | 2005-03-04 | 2006-09-14 | Northwestern University | Angiogenic heparin binding peptide amphiphiles |
| US8497101B2 (en)* | 2005-05-13 | 2013-07-30 | Centre National De La Recherche Scientifique (Cnrs) | Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions |
| CA2614421A1 (en) | 2005-07-08 | 2007-01-18 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
| WO2007014338A2 (en)* | 2005-07-26 | 2007-02-01 | Siemens Medical Solutions Diagnostics | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| WO2007037601A1 (en)* | 2005-09-28 | 2007-04-05 | Knu-Industry Cooperation Foundation | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| DK1969003T3 (en) | 2005-12-14 | 2010-12-13 | Hermo Pharma Ltd | Applications of a neurotrophic factor protein |
| CN101506376A (en)* | 2006-07-03 | 2009-08-12 | 埃克森希特医疗股份有限公司 | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| WO2008030559A2 (en)* | 2006-09-08 | 2008-03-13 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
| US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
| US8999634B2 (en)* | 2007-04-27 | 2015-04-07 | Quest Diagnostics Investments Incorporated | Nucleic acid detection combining amplification with fragmentation |
| GB0805159D0 (en)* | 2008-03-19 | 2008-04-23 | Sancho Madrid David | Immune modulation via C-type lectin |
| UA103751C2 (en) | 2007-07-27 | 2013-11-25 | Имматикс Биотекнолоджис Гмбх | Immunogenic peptide for immunotherapy |
| US7863021B2 (en)* | 2007-09-05 | 2011-01-04 | Celera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
| WO2009034661A1 (en)* | 2007-09-12 | 2009-03-19 | Toppan Printing Co., Ltd. | Method for diagnosis and induction of resistance to virus |
| JP2011500047A (en) | 2007-10-17 | 2011-01-06 | ウニベルシダ・ドゥ・コルドバ | Human somatostatin receptor type 5 isoforms produced by alternative processing and oligonucleotide pairs for their detection by PCR |
| AU2008345242B2 (en) | 2007-10-31 | 2014-02-27 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| WO2009115612A1 (en)* | 2008-03-21 | 2009-09-24 | Universiteit Hasselt | Biomarkers for rheumatoid arthritis |
| US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
| CN102164611B (en) | 2008-07-24 | 2015-01-07 | Ns基因公司 | Therapeutic use of the growth factor METRNL |
| PT2172211E (en)* | 2008-10-01 | 2015-03-09 | Immatics Biotechnologies Gmbh | COMPOSITION OF TUMOR-RELATED PEPTIDES AND RELATED ANTI-CANCER VACCINE FOR THE TREATMENT OF GLIOBLASTOM (GBM) AND OTHER TYPES OF CANCER |
| EP2358908B1 (en) | 2008-11-14 | 2014-01-08 | Gen-Probe Incorporated | Compositions and methods for detection of campylobacter nucleic acid |
| WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| CA2745849A1 (en)* | 2008-12-09 | 2010-06-17 | Alethia Biotherapeutics Inc. | Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| CA2758522A1 (en) | 2009-04-13 | 2010-10-21 | Northwestern University | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
| US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| EP2528615B1 (en) | 2010-01-27 | 2020-05-13 | Massachusetts Institute of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| CA2811644C (en) | 2010-09-29 | 2022-07-12 | Agensys, Inc. | Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| CN103269708A (en) | 2010-10-01 | 2013-08-28 | Ns基因公司 | Use of Meteorin for the Treatment of Allodynia, Hyperalgesia, Spontaneous Pain and Phantom Pain |
| WO2012081040A1 (en)* | 2010-12-14 | 2012-06-21 | Hananja Ehf. | Biological activity of placental protein 13 |
| WO2013034157A1 (en) | 2011-09-05 | 2013-03-14 | Nsgene A/S | Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
| AR088699A1 (en)* | 2011-11-09 | 2014-06-25 | Sanofi Sa | DIACILGLICEROL LIPASA AND USES OF THE SAME |
| DK2844667T3 (en) | 2012-04-30 | 2018-07-30 | Biocon Ltd | Targeted / immunomodulatory fusion proteins and methods for their preparation |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| WO2013173364A2 (en) | 2012-05-14 | 2013-11-21 | Biogen Idec Ma Inc. | Lingo-2 antagonists for treatment of conditions involving motor neurons |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| NZ707831A (en) | 2012-11-13 | 2018-11-30 | Astellas Pharma Inc | Agents for treatment of claudin expressing cancer diseases |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| RU2698975C2 (en) | 2013-03-12 | 2019-09-02 | Биокон Лтд. | Fused immunomodulatory proteins and methods for production thereof |
| US9023353B2 (en) | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| AU2014241162A1 (en) | 2013-03-27 | 2015-10-22 | Cedars-Sinai Medical Center | Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways |
| PT3019619T (en) | 2013-07-11 | 2021-11-11 | Modernatx Inc | COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING SYNTHETIC CRISPR AND SGARN-RELATED PROTEINS AND METHODS OF USE |
| WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
| CN106163556B (en) | 2013-09-25 | 2024-04-09 | 西托姆克斯治疗公司 | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof |
| JP6558699B2 (en)* | 2013-10-01 | 2019-08-14 | 国立大学法人三重大学 | T cell-derived vaccine containing an inter-epitope sequence that promotes antigen presentation |
| CN106459153B (en) | 2014-01-31 | 2021-12-21 | 西托姆克斯治疗公司 | Substrates and other cleavable moieties for proteolytic enzymes and U-type plasminogen activators and methods of use thereof |
| AU2016205197B2 (en) | 2015-01-08 | 2021-10-21 | Biogen Ma Inc. | LINGO-1 antagonists and uses for treatment of demyelinating disorders |
| MA41374A (en) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF |
| WO2016201077A1 (en)* | 2015-06-12 | 2016-12-15 | Emory University | Growth and survival compositions for cells capable of producing antibodies and methods related thereto |
| EP3344776B1 (en) | 2015-09-04 | 2021-06-16 | Synthetic Genomics, Inc. | Rekombinant algal microorganism with increased productivity |
| CN118773299A (en) | 2016-03-17 | 2024-10-15 | 西达-赛奈医疗中心 | Method for diagnosing inflammatory bowel disease through RNASET2 |
| EP3436069A4 (en)* | 2016-03-29 | 2019-12-18 | Valkyrie Therapeutics Inc. | MODULATION OF THE STRUCTURAL MAINTENANCE OF CHROMOSOME-1 EXPRESSION |
| US9611297B1 (en) | 2016-08-26 | 2017-04-04 | Thrasos Therapeutics Inc. | Compositions and methods for the treatment of cast nephropathy and related conditions |
| US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
| EP3508499A1 (en) | 2018-01-08 | 2019-07-10 | iOmx Therapeutics AG | Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof |
| US12257340B2 (en) | 2018-12-03 | 2025-03-25 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| MX2021006429A (en) | 2018-12-06 | 2021-07-15 | Cytomx Therapeutics Inc | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof. |
| AU2020261435A1 (en)* | 2019-04-26 | 2021-11-25 | Sangamo Therapeutics, Inc. | Engineering AAV |
| EP3994171A1 (en) | 2019-07-05 | 2022-05-11 | iOmx Therapeutics AG | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
| US12280096B2 (en) | 2021-07-12 | 2025-04-22 | Penland Foundation | Treatments of cancer using nitrous oxide and botulinum toxin |
| WO2021083958A1 (en)* | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
| JP7531931B2 (en)* | 2020-03-27 | 2024-08-13 | ワンキュアジェン カンパニー，リミテッド | Composition for treating cancer comprising VGLL1 peptide |
| US20230212243A1 (en)* | 2020-05-12 | 2023-07-06 | Institut Curie | Neoantigenic Epitopes Associated with SF3B1 Mutations |
| EP4150079A1 (en) | 2020-05-15 | 2023-03-22 | Crispr Therapeutics AG | Messenger rna encoding cas9 for use in genome-editing systems |
| WO2022008027A1 (en) | 2020-07-06 | 2022-01-13 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
| CA3205170A1 (en)* | 2021-01-21 | 2022-07-28 | Johannes Eduard Maria Antonius Debets | T cells for use in therapy |
| WO2022178318A1 (en)* | 2021-02-18 | 2022-08-25 | Beren Therapeutics P.B.C. | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins |
| US20240158457A1 (en)* | 2022-05-20 | 2024-05-16 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |